Biological evaluation and applicable biocompatibility testing to support the assessment of medical devices and materials for their intended contact with the human body.
Material verification plays an important role in evaluating materials used in medical devices and surgical instruments.
Medical devices and materials that come into contact with the human body should be evaluated for potential biological risks associated with their intended use.
Biocompatibility evaluation considers the interaction between a medical device or material and the biological system with which it comes into contact. The objective is to identify and evaluate potential biological effects while supporting the overall safety assessment of the device.
At Veritas Lab Testing, biocompatibility testing can be structured according to the characteristics of the device, materials, manufacturing processes, sterilisation and packaging conditions, intended body contact, and duration of contact.
The appropriate biological endpoints are not identical for every medical device. Depending on the device and its biological risk profile, evaluation may include cytotoxicity, irritation, sensitisation, systemic toxicity, genotoxicity, implantation, haemocompatibility, chemical characterisation, toxicological risk assessment, or other applicable endpoints.
Material composition
Grade verification
Technical requirements
Testing capabilities can be tailored according to the material, product, applicable specifications, and intended requirements.
Evaluation of the potential cytotoxic effects of a medical device or material using appropriate in-vitro biological methods.
Cytotoxicity testing evaluates whether substances released from a medical device or material can produce adverse effects on cultured cells under defined test conditions. The applicable method and sample preparation depend on the device, material, intended use, and applicable requirements.
Evaluation of the potential of a medical device or material to cause local irritation following relevant exposure.
Irritation evaluation may consider the intended contact of the device with skin, mucosal tissue, or other relevant body sites. The applicable test approach depends on the device category, contact characteristics, exposure duration, and biological evaluation strategy.
Testing requirements may vary depending on the material, product, intended use, applicable specification, and target market.
Review the device design, materials, components, manufacturing process, sterilisation, packaging, intended use, body contact, and duration of contact.
Identify relevant biological risks and determine the appropriate biological evaluation strategy based on the device characteristics, materials, contact category, exposure duration, and available information.
Establish the applicable biological endpoints, test methods, sample requirements, controls, acceptance criteria, and evaluation conditions according to the device and applicable requirements.
Testing requirements can differ between products, customers, and markets. Our technical documentation can support manufacturers preparing for international business requirements.
Biocompatibility information can support medical-device manufacturers preparing technical documentation for products intended for the United States market. Applicable biological evaluation should be established according to the device and relevant regulatory requirements.
Biological evaluation and applicable testing can support technical documentation for medical devices intended for the European market, according to the device characteristics and applicable requirements.
Clear documentation helps manufacturers understand and use testing results within their quality and technical documentation processes.
Risk-Based Biological Evaluation
Biocompatibility evaluation should be based on the characteristics and biological risks of the specific medical device rather than applying the same tests to every product.
Device and Material Considerations
The biological evaluation can consider device materials, components, manufacturing processes, processing conditions, sterilisation, packaging, and other factors that may influence biological safety.
Nature and Duration of Body Contact
The appropriate biological endpoints depend in part on how the device contacts the body and how long the contact occurs. Different contact conditions can result in different biological evaluation requirements.
Biological Endpoints
Depending on the device and risk assessment, applicable evaluations may include cytotoxicity, irritation, sensitisation, systemic toxicity, genotoxicity, implantation, haemocompatibility, chemical characterisation, and toxicological risk assessment.
Integration With Technical Documentation
Biocompatibility test results can contribute to the manufacturer's overall biological evaluation and technical documentation when the testing strategy, methods, standards, and conclusions are appropriate for the device and intended market.
Biocompatibility testing is part of the biological evaluation of a medical device and helps assess whether the device or its materials may produce unacceptable biological effects during intended use.
No. Biocompatibility is an overall biological evaluation. Different medical devices may require different biological endpoints depending on their materials, intended use, body contact, and exposure duration.
The ISO 10993 series provides a framework and individual standards for different aspects of biological evaluation. ISO 10993-1 provides the general principles for biological safety evaluation within a risk-management framework.
No. The applicable endpoints depend on the characteristics of the individual device and its intended use. A risk-based evaluation is used to determine which endpoints need to be addressed.
Share your device details, materials, intended use, and testing requirements with our team. We can help identify an appropriate biological evaluation and testing approach for your product.
Evaluation of the potential for a medical device or material to cause an adverse immune-mediated sensitisation response.
Sensitisation testing evaluates whether exposure to substances associated with a medical device or material may produce a sensitising response. The applicable method and test strategy should be selected according to the device characteristics and biological risk assessment.
Evaluation of potential effects of a medical device or material on genetic material.
Genotoxicity evaluation may include appropriate testing for gene mutations, chromosomal damage, or other relevant genetic effects. The selected tests depend on the device, materials, chemical information, exposure conditions, and applicable biological evaluation requirements.
Evaluation of the interaction between blood and medical devices or materials intended for blood contact.
Hemocompatibility testing evaluates potential effects of a blood-contacting medical device on blood or blood components. Depending on the device and intended application, evaluations may address relevant haematological, coagulation, platelet, or thrombosis-related effects.
Assessment of potential systemic biological effects or pyrogenic responses associated with medical devices and materials.
Systemic toxicity and pyrogenicity evaluations consider whether substances associated with a medical device can produce systemic biological effects or fever-producing responses. The appropriate evaluation depends on the device, exposure conditions, materials, and applicable requirements.
Evaluation of the local biological response to medical devices or materials intended for implantation or prolonged tissue contact.
Implantation testing evaluates the biological response of surrounding tissue to a medical device or material under defined conditions. The evaluation may include macroscopic and microscopic assessment as appropriate to the device and study design.
Evaluation of chemical substances that may be released from medical devices and assessment of their potential toxicological risks.
Chemical characterisation can identify and quantify relevant extractables and leachables associated with a medical device. Where applicable, toxicological risk assessment can be used to evaluate the potential biological significance of identified substances based on exposure and available toxicological information.
Specific standards and testing requirements should be confirmed before testing based on the product and applicable technical requirements.
Prepare the device, material, extracts, or other required test articles according to the selected test method and applicable sample preparation requirements.
Conduct the selected biological evaluations under defined test conditions using appropriate procedures, controls, and documentation.
Evaluate the test results against the defined criteria and document the methods, observations, results, and conclusions in a technical report suitable for supporting the manufacturer's biological evaluation and technical documentation.
Biocompatibility testing can support manufacturers and suppliers preparing technical documentation for medical devices intended for the United Kingdom market.
Biological testing and supporting documentation can assist medical-device manufacturers and exporters supplying products to Middle Eastern markets.
Biocompatibility evaluation may also support technical documentation and product safety assessment for medical devices supplied to other international markets.
Yes. Cytotoxicity is one of the biological endpoints that may be considered within a medical-device biological evaluation. Its applicability depends on the device and intended use.
Not necessarily. The biological evaluation can consider the medical device in its finished form, including relevant materials, components, manufacturing processes, and applicable sterilization conditions.
Depending on their materials, intended use, tissue contact, and exposure conditions, surgical instruments may require appropriate biological evaluation.
Biological evaluation and applicable test reports can contribute to technical documentation or regulatory submissions. The exact requirements depend on the target market, device, and applicable regulatory pathway.
No. A single successful test does not automatically establish overall biological safety. The complete evaluation depends on the relevant biological endpoints and the characteristics of the device.